Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Mkilloran who wrote (18477)	2/1/1999 9:04:00 PM
From: VLAD	Respond to of 23519

Here is an e-mail I got from Astra today. It is a response to an e-mail I sent back on December 24th asking about specifics of the ED market in Sweden: Dear Dr [ ] In Sweden, MUSE was launched in July 1998 - Viagra in September 1998. Unfortunately, we do not like in the US have any weekly prescription data. Astra reports full year 1998 results on February 16 - so I am afraid that I can only be rather limited in my comments. Nevertheless, I can say that Viagra to some extent has "helped" us in Sweden, as it strongly has expanded the market for erectile dysfunction. Kind regards, Michael Olsson Manager, Investor Relations _____________________________________________________________ ASTRA AB PR & Information, S-151 85 Sodertalje, Sweden Tel: +46 8 553 259 52 Fax: +46 8 553 288 10 E-mail: michael.olsson@astra.se.astra.com Astra's 1998 report may have some insight in it regarding Astra's plans for further launches in Europe etc...